Ethics of Surrogacy During COVID-19 Pandemic
By Cathy Sakimura and Emily Galpern,
Men Having Babies
| 05. 12. 2021
The COVID pandemic has placed new hurdles to having a child through surrogacy, complicating international surrogacy in particular by restricting travel, delaying birth certificates and visas, and introducing specific considerations about safety and well-being. In addition, the pandemic has created new challenges to engaging in international surrogacy ethically due to changes in how healthcare is administered, limiting face-to-face interactions, and of course, increasing the health risks for everyone involved – women and other people acting as surrogates and egg donors, genetic intended parents undergoing medical procedures, and babies born through surrogacy. These challenges continue even as the landscape of the pandemic changes, given variation between countries in vaccination access.
What does it mean to approach international surrogacy ethically? An ethical approach strives to minimize the effects of gender, economic, global, and racial inequities that impact the bargaining power of people acting as surrogate or egg donors. The vast majority of people acting as surrogates and egg donors are women, and addressing the impact of gender inequality and the control and regulation of women’s bodies are core aspects of an ethical...
Related Articles
By Grace Won, KQED [with CGS' Katie Hasson] | 12.02.2025
In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby. But according to the Wall Street Journal, Bay Area startups are focused on just that. It wouldn’t be the first...
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Lucy Tu, The Guardian | 11.05.2025
Beth Schafer lay in a hospital bed, bracing for the birth of her son. The first contractions rippled through her body before she felt remotely ready. She knew, with a mother’s pit-of-the-stomach intuition, that her baby was not ready either...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...